Articles From: Redesigned Website Helps Electrical Equipment Design Engineers Find 3M Solutions Faster to Redtail Technology and Morningstar Work Together to Simplify Advisor Practice through Redtail's Enhanced CRM User Interface


2014/10/14
A new website from 3M helps electrical design engineers to find 3M solutions for design and performance challenges facing manufacturers of electrical equipment.
Sign-up for Redesigned Website Helps Electrical Equipment Design Engineers Find 3M Solutions Faster investment picks
RedEye , a Stratasys Company (Nasdaq:SSYS) and leading provider of 3D printing and additive manufacturing services, has partnered with NASA’s Jet Propulsion Laboratory (JPL) to 3D print 30 antenna array supports for the FORMOSAT-7 Constellation Observing System for Meteorology, Ionosphere, and Climate (COSMIC-2) satellite mission.
Sign-up for RedEye 3D Prints Functional Antenna Arrays for NASA COSMIC-2 Satellites investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0980996001&sourceType=1 http://www.ccnmatthews.com/logos/20080424-Redhawk%20Large.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Redhawk Announces Closing of Joint Venture With Anglo American on Copper Creek Project investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0969922001&sourceType=1 http://www.ccnmatthews.com/logos/20080424-Redhawk%20Large.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Redhawk Announces Election of Directors investment picks
The German Federal Institute for Drugs and Medical Devices (BfArM) has validated the European Marketing Authorization Application submitted for RIZAPORT ™ (RHB-103) and initiated its formal review of the application on November 25, 2014 RedHill and IntelGenx continue to work with the FDA to resolve the remaining Chemistry, Manufacturing and Controls (CMC) issues and secure a compliant source of the raw material, in order to advance potential FDA approval of the U.S. New Drug Application submitted by the companies RIZAPORT ™ oral thin film formulation of rizatriptan for acute migraines presents a potentially attractive therapeutic alternative for many migraine patients, including those suffering from migraine-related nausea, due to its convenient dosing, lack of need for water intake and pleasant flavoring TEL-AVIV, Israel, Dec.
Sign-up for RedHill Biopharma and IntelGenx Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines investment picks
The randomized, double-blind, placebo-controlled, parallel group Phase III study with RHB-102 (the GUARD study) will enroll 320 acute gastroenteritis patients in the U.S. Acute gastroenteritis is an inflammation of the gastrointestinal tract causing nausea and vomiting, with a potential worldwide market estimated to exceed $650 million If approved for marketing by the FDA, RHB-102 is expected to be the first-ever 5-HT3 antagonist drug indicated for acute gastroenteritis Dr.
Sign-up for RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis investment picks
In order to enhance statistical powering and expedite recruitment, RedHill has increased the number of subjects and clinical sites, respectively, in the ongoing RHB-105 Phase III ERADICATE Hp study, with top-line data currently expected in the first half of 2015 FDA has permitted RedHill to pursue with RHB-105 a significantly broader indication than that of existing H.
Sign-up for RedHill Biopharma Provides Update on Expansion of Ongoing RHB-105 Phase III Study, Targeting Broadened H. pylori Indication Authorized by FDA investment picks
A strong cash position of approximately $29 million at the end of the third quarter of 2014, enabling the Company to continue to execute its R&D programs including the three ongoing Phase III studies in gastrointestinal indications: RHB-104 for Crohn's disease, RHB-105 for H.
Sign-up for RedHill Biopharma Reports Results for the Third Quarter of 2014 investment picks
TEL-AVIV, Israel, Oct.
Sign-up for RedHill Biopharma to Present at the 20th Annual BIO-Europe International Partnering Conference investment picks
TEL-AVIV, Israel, Sept.
Sign-up for RedHill Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference investment picks
Rediff.com India Limited (Nasdaq: REDF), one of the premier worldwide online providers of news, information, communication, entertainment, mobile and shopping services, will release its results for the Second Quarter Ended September 30, 2014 at 8:30 am ET (5:30 am Pacific Time / 6:00 pm India Time) on Wednesday, October 22, 2014.
Sign-up for Rediff.com India Limited Schedules Second Quarter Ended September 30, 2014 investment picks
Redknee Advances Position in Gartner IRCM Magic Quadrant Canada NewsWire TORONTO , Nov.
Sign-up for Redknee Advances Position in Gartner IRCM Magic Quadrant investment picks
Redknee Enables Oi to Successfully Leverage Virtualization Canada NewsWire TORONTO , Oct.
Sign-up for Redknee Enables Oi to Successfully Leverage Virtualization investment picks
Redknee Recognized by Telecom Review as Best OSS/BSS Provider Canada NewsWire TORONTO , Nov.
Sign-up for Redknee Recognized by Telecom Review as Best OSS/BSS Provider investment picks
Redknee Recognized in Deloitte's 2014 Technology Fast 500™ Canada NewsWire TORONTO , Nov.
Sign-up for Redknee Recognized in Deloitte's 2014 Technology Fast 500™ investment picks
Redknee Signs $13 Million Dollar Strategic Order with Leading APAC Enterprise Canada NewsWire TORONTO , Nov.
Sign-up for Redknee Signs $13 Million Dollar Strategic Order with Leading APAC Enterprise investment picks
Redknee Signs $8 Million Dollars of Orders with Operator in the Americas Canada NewsWire TORONTO , Sept.
Sign-up for Redknee Signs $8 Million Dollars of Orders with Operator in the Americas investment picks
Redknee Solutions Inc. to Host Fiscal Fourth Quarter and 2014 Year-End Results Investor Conference Call on November 20, 2014 Canada NewsWire TORONTO , Oct.
Sign-up for Redknee Solutions Inc. to Host Fiscal Fourth Quarter and 2014 Year-End Results Investor Conference Call on November 20, 2014 investment picks
2014/11/19
Redknee Solutions Reports Fiscal Fourth Quarter and Full Year 2014 Results Canada NewsWire Fiscal Q4 2014 Financial Highlights (Comparisons made between fiscal Q4 FY2014 and fiscal Q4 FY2013 results, unless otherwise noted) Revenue totaled $60.9 million , up 6% from $57.4 million Gross profit was $36.1 million (59% of total revenue) compared to $30.8 million (54% of total revenue) Adjusted EBITDA of $5.8 million versus Adjusted EBITDA of $4.5 million Total cash at $109.5 million ; cash generation from operations totaled $20 million Accounts receivable decreased by $14.3 million to $71.4 million compared to Q3 FY2014 Unbilled revenue decreased by $8.0 million to $42.4 million compared to Q3 FY2014 Restructuring costs totalled $22.5 million to reduce annual overall expenses by $30 million to $35 million by fiscal 2016 Net loss totaled $34.7 million
Sign-up for Redknee Solutions Reports Fiscal Fourth Quarter and Full Year 2014 Results investment picks
Redknee Supports Service Provider in the Americas to Rapidly Launch New Brand Canada NewsWire TORONTO , Dec.
Sign-up for Redknee Supports Service Provider in the Americas to Rapidly Launch New Brand investment picks
Redknee Supports SingTel Optus Wholesale Canada NewsWire TORONTO , Oct.
Sign-up for Redknee Supports SingTel Optus Wholesale investment picks
Redline Boosts M2M Network Security with TrustPoint Canada NewsWire TORONTO , Oct.
Sign-up for Redline Boosts M2M Network Security with TrustPoint investment picks
Redline Communications Acquires PureWave Networks Assets Canada NewsWire Acquisition Increases Breadth of Redline's Technology and Patent Portfolio TORONTO , Sept.
Sign-up for Redline Communications Acquires PureWave Networks Assets investment picks
Redline Communications Reports Q3 2014 Results Canada NewsWire TORONTO , Nov.
Sign-up for Redline Communications Reports Q3 2014 Results investment picks
New Redtail CRM User Interface Incorporates Morningstar's Proprietary Research and Analytics GOLD RIVER, Calif.
Sign-up for Redtail Technology and Morningstar Work Together to Simplify Advisor Practice through Redtail's Enhanced CRM User Interface investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Redesigned Website Helps Electrical Equipment Design Engineers Find 3M Solutions Faster to Redtail Technology and Morningstar Work Together to Simplify Advisor Practice through Redtail's Enhanced CRM User Interface
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent